OKUR OnKure Therapeutics, Inc. Class A Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

OnKure Therapeutics (OKUR) Stock: Buy, Sell, or Hold?

$2.70
-0.06 (-2.17%) â–ŧ
5d: +2.66% 30d: +4.65% 90d: -30.59%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
34/100
Position
FAIR
30-Day Fair Range
$2.26 – $2.90
Position: FAIR
Forward P/E & Valuation
-1.7x
Next 12M consensus est.
Wall Street Target
$15.25
+464.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.50 / $3.59
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: OKUR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When OKUR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: OKUR is currently trading at $2.70, which is considered fair relative to its 30-day fair value range of $2.26 to $2.90.

Technical Outlook: Technically, OKUR is in a strong downtrend. Immediate support is located at $2.50, while resistance sits at $3.59.

Market Sentiment: OKUR scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $15.25 (+464.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $2.26 - $2.90
Company Quality Score 34/100 (SELL)
Volume Confirmation HIGH
Confidence Score 50.0%

Trading Range & Key Levels

30-Day Trading Range $2.26 - $2.90
Current vs Trading Range FAIR
Support Level $2.50
Resistance Level $3.59
Current Trend Strong Downtrend
Technical data as of Nov 20, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Phase & Gamma Walls SURGE
Days in Phase: 8d (50% conf)
30D Insider Cluster Signal TRACKED
30D Insider Buyers: 0 insiders ($0)
30D Net Insider Flow: $-1,157

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (20/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 464.8% below Wall St target ($15.25)
  • WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -1.66
Wall Street Target $15.25 (+464.8%)
Share OKUR Analysis

Share this live OKUR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (OKUR)

Bullish 1 Retail Mentions
Retail Stream Volume
1 msgs
24h retail stream
Last Tracked
Oct 23, 2026
Daily AI digest
AI Retail Discussion Summary: A user on StockTwits expresses bullish sentiment towards $OKUR, praising the Starlight community as the best small-cap community they've found. No recent news articles were available.
Key Retail Themes: positive sentiment towards $OKUR recommendation to join the Starlight community
Aggregated from r/wallstreetbets, r/stocks & retail trader streams. View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 7:03 AM ET
Data refreshes hourly during market hours. Next update: 8:03 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for OKUR.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RVMD
Revolution Medicines Inc
STRONG BUY
24 analysts
$275 58 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
21 analysts
$95 38 SELL
JANX
Janux Therapeutics Inc
STRONG BUY
18 analysts
$33 53 HOLD
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
18 analysts
$72 37 SELL
SNDX
Syndax Pharmaceuticals Iâ€Ļ
STRONG BUY
12 analysts
$35 61 BUY
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals